StockDrifts LogoStockDrifts

Femtobiomed 327610

Company
펨토바이오메드Femtobiomed
Insiders
1
Buys
14
Total Value
₩36M ($25K)
Avg Return
-81.83%
Last Filing
2025-11-05

Femtobiomed (327610) has 14 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩36M ($25K) in reported transaction value. The earliest filing StockDrifts holds for Femtobiomed is dated 2021-07-27; the most recent is 2025-11-05. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is -81.83%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2025-11-05BUY장외매수
이상현
Sanghyun Lee
CEO20.7K₩2,045-48.9%₩42M ($29K)
2025-06-17BUYMarket Buy
이상현
Sanghyun Lee
CEO334₩5,380-80.6%₩2M ($1K)
2025-06-16BUYMarket Buy
이상현
Sanghyun Lee
CEO100₩5,780-81.9%₩578K ($401)
2025-06-13BUYMarket Buy
이상현
Sanghyun Lee
CEO200₩5,690-81.6%₩1M ($790)
2025-06-12BUYMarket Buy
이상현
Sanghyun Lee
CEO200₩6,000-82.6%₩1M ($833)
2025-06-11BUYMarket Buy
이상현
Sanghyun Lee
CEO200₩5,290-80.3%₩1M ($735)
2025-06-10BUYMarket Buy
이상현
Sanghyun Lee
CEO300₩4,600-77.3%₩1M ($958)
2025-06-09BUYMarket Buy
이상현
Sanghyun Lee
CEO700₩4,000-73.9%₩3M ($2K)
2025-06-05BUYMarket Buy
이상현
Sanghyun Lee
CEO2.9K₩3,910-73.3%₩11M ($8K)
2025-06-04BUYMarket Buy
이상현
Sanghyun Lee
CEO1.3K₩3,400-69.3%₩4M ($3K)
2025-06-02BUYMarket Buy
이상현
Sanghyun Lee
CEO2.4K₩2,985-65.0%₩7M ($5K)
2025-05-29BUY상속
이상현
Sanghyun Lee
CEO1.7K₩3,430-69.5%₩6M ($4K)
2025-03-26BUY신규선임
황운봉
Hwangunbong Peak
moving31.5K₩4,400-76.3%₩139M ($96K)
2021-07-30BUYMarket Buy
이상현
Sanghyun Lee
CEO8₩20,900-95.0%₩167K ($116)
2021-07-30BUYMarket Buy
이상현
Sanghyun Lee
CEO34₩20,900-95.0%₩711K ($493)
2021-07-30BUYMarket Buy
이상현
Sanghyun Lee
CEO85₩20,900-95.0%₩2M ($1K)
2021-07-30BUYMarket Buy
이상현
Sanghyun Lee
CEO45₩20,900-95.0%₩941K ($653)
2021-07-27BUY무상신주취득
이상현
Sanghyun Lee
CEO1.3M₩21,600-95.2%₩27.5B ($19.1M)

Frequently asked questions

Who has been buying Femtobiomed stock?
1 distinct insiders have filed 14 disclosed insider purchases in Femtobiomed (327610), most recently on 2025-11-05. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Femtobiomed have?
Femtobiomed has 14 buy-side and 0 sell-side disclosures on record, covering ₩36M ($25K) in total reported value, spanning 2021-07-27 to 2025-11-05.
Where does StockDrifts get Femtobiomed insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Femtobiomed. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.